AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Morglin-M Tablet ER

Prescription Icon
Prescription Required

Marketer

Morningg Life Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Morglin-M Tablet ER

Duo-Control XR tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This helps prevent severe diabetic complications like nephropathy and vision loss, and may decrease the risk of cardiovascular events. Duo-Control XR can be used alone or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to your individual health status, glucose levels, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Effective blood sugar control helps mitigate future complications. Maintaining the prescribed diet and exercise regimen is crucial. Lifestyle choices are integral to diabetes management. Common side effects include diarrhea, nausea, vomiting, dyspepsia, and headache. Hypoglycemia is a potential side effect, especially with concurrent use of insulin or sulfonylureas; learn how to recognize and manage it. This medication isn't suitable for all patients. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating women should seek medical advice. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Uses of Morglin-M Tablet ER

Managing Type 2 Diabetes

Major Benefits of Morglin-M Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Morglin-M Extended Release tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.

Common Side effects of Morglin-M Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Morglin-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Morglin-M Extended-Release tablets. Ingest the tablets whole; do not crush, chew, or break them. Consume Morglin-M ER with a meal.

How Morglin-M Tablet ER works:

Extended-release Morglin-M tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Morglin-M Tablet ER and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Morglin-M tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Morglin-M tablets pose a likely risk during lactation. Available human evidence indicates potential drug transfer to breast milk, possibly causing infant harm.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Morglin-M Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Morglin-M Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Morglin-M Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The extended-release Morglin-M Tablet is likely contraindicated for individuals with hepatic impairment and its use should be avoided. Physician consultation is recommended.

What if you forget to take Morglin-M Tablet ER :

Should you forget a Morglin-M Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Morglin-M Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Medication

FAQs on Morglin-M Tablet ER

Morglin-M Tablet ER is safe when used as prescribed. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also using insulin or sulfonylurea. Report any persistent side effects to your doctor.
Morglin-M Tablet ER rarely causes hypoglycemia by itself, but low blood sugar can result from inadequate caloric intake while using it. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Morglin-M Tablet ER may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Contact your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Morglin-M Tablet ER is contraindicated in patients allergic to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Morglin-M Tablet ER can cause lactic acidosis (MALA), a rare but serious side effect characterized by excessive blood lactic acid. This risk is higher in individuals with kidney disease, older adults, or those who consume significant alcohol. Symptoms may include muscle aches or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these symptoms, discontinue Morglin-M Tablet ER and seek immediate medical attention.
Prolonged Morglin-M Tablet ER use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. If you experience these symptoms, consult your doctor for B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Morglin-M Tablet ER
98
MRP 119
17% off